Cystamine Inhibits HIV Type 1 Replication in Cells of Monocyte/Macrophage and T Cell Lineages
Authors:
- Xian-Hua ZhuXZXian-Hua Zhu
- Li SongLSLi Song
- Hae-Ran LeeHLHae-Ran Lee
- Joann R. CutilliJCJoann R. Cutilli
- Steven D. DouglasSDSteven D. Douglas
- 1 April 1995
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 11 (4) , 451-459
Abstract
The effects of cysteamine (2-aminoethanethiol, MEA) and its disulfide, cystamine, on the human immunodeficiency virus (HIV-1) expression in chronically infected promonocytic cells (U1), T cell line (ACH-2), and peripheral blood monocyte-derived macrophages (MDM) were investigated. U1 and ACH-2 cells constitutively express low levels of virus, which is increased by the addition of tumor necrosis factor (TNF-α), interleukin 6 (IL-6), granulocyte-macrophage-colony-stimulating factor (GM-CSF), and other inducers. Cystamine, in noncytotoxic doses, suppressed in a concentration-dependent fashion the induction of HIV-1 expression mediated by TNF-α, IL-6, GM-CSF, and monokine-enriched monocyte culture supernatants in both U1 and ACH-2 cells as determined by HIV-1 reverse transcriptase (RT) activity. Similarly, HIV-1 expression was substantially reduced in the cystamine-treated primary MDM cultures compared with the untreated control cultures. The addition of cystamine into HIV-1 chronically infected MDM (12 days after infection was established) also suppressed 80-90% of RT activity in comparison to the untreated controls. HIV-1 (Bal) infected MDM cultures (without cystamine treatment) demonstrated giant syncytium formation, whereas cystaminetreated cultures lacked the giant syncytia induced by HIV-1 infection. Cystamine also inhibited LPS-induced TNF production in MDM. In contrast to cystamine, cysteamine showed no significant effects on either the monokine-induced HIV-1 expression in U1 or ACH-2 or acute and chronic HIV-1 infection in MDM. Thus, these observations indicate that cystamine may have the potential to limit HIV-1 replication in T cells and MDM in vivo and may be a member of new class of drugs with anti-HIV-1 effects.Keywords
This publication has 32 references indexed in Scilit:
- Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.Journal of Clinical Investigation, 1994
- Resistance of Human Immunodeficiency Virus Type 1 to Antiretroviral Agents: A ReviewClinical Infectious Diseases, 1994
- Glutathione and N-Acetylcysteine Suppression of Human Immunodeficiency Virus Replication in Human Monocyte/Macrophages In VitroAIDS Research and Human Retroviruses, 1992
- N -Acetylcysteine: A New Approach to Anti-HIV TherapyAIDS Research and Human Retroviruses, 1992
- Effect of cytokines and lipopolysaccharides on HIV infection of human macrophagesResearch in Virology, 1991
- N-Acetylcysteine Inhibits Latent HIV Expression in Chronically Infected CellsAIDS Research and Human Retroviruses, 1991
- Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected PatientsBiological Chemistry Hoppe-Seyler, 1989
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Effects of Cysteamine Therapy in Nephropathic CystinosisNew England Journal of Medicine, 1981
- Protection Against X-rays and Therapy of Radiation Sickness with β-MercaptoethylamineScience, 1953